Upon successful completion of this free training and the associated case assessment, eligible participants may apply to the relevant state departments of health for authority to prescribe Section 100 (s100) drugs for the management of hepatitis B in Australia.

Scholarship Applications Now Open!

ASHM is pleased to offer a limited number of scholarships to support attendance at this event. Scholarships may cover (travel and accommodation costs, flights and taxi reimbursement). Applications are open to individuals who are part of the event’s target audience and will be assessed based on submission time, financial need, and other extenuating circumstances. While we aim to support as many people as possible, we are only able to provide scholarships to a small number of applicants who require assistance to attend. Successful applicants will be notified by July, 24 2026.

Click here to apply for a scholarship.

Date, Time, Platform:

• Venue: TBC- Perth
• Date: Saturday, 15 August 2026
• Time: 9:00am –1:00pm (AWST)

Learning Outcomes:

On completion of this course and its components, participants will be able to:

• Outline the critical role of primary care in the diagnosis, management and treatment of people living with chronic hepatitis B
• Plan long-term care, including guideline-based monitoring and hepatocellular carcinoma screening, for patients with chronic hepatitis B
• Select and prescribe first-line antiviral treatment when clinically indicated
• Identify situations where specialist advice or referral is required
• Integrate principles of person-centred and culturally competent care into hepatitis B management

Course Components:

This course will be presented as a mix of virtual, self-paced and live facilitated learning, providing attendees an opportunity to discuss and practice strategies with peers and specialists. This is comprised of:

• Online Learning Modules
• One 4 hour live session
• Case Studies
• Multiple choice quizzes
• Presentations and case discussions will be delivered by specialists and primary care providers with expertise in hepatitis B.

Total expected time to complete all self-paced and live components = 9.5hrs

Recommended Resources:

• Decision Making in Hepatitis B | ASHM

CPD & Endorsement:

• RACGP: This course has been approved as a CPD activity by RACGP for the 2026-2028 triennium. Educational Activities: 7. Reviewing Performance: 2.5. Please provide your full RACGP member number and name on your MyASHM Profile so we can report attendance to RACGP on your behalf.
• ACRRM: This event has been accredited in the 2026-2028 ACRRM CPD Program for: 4 Educational Activity Hours, 0.5 Performance Review hours. Please provide your full ACRRM member number and name on your MyASHM Profile so we can report attendance to ACRRM on your behalf.
• ACNP: This course is pending approval by ACNP. This activity is pending endorsement by the Australian College of Nurse Practitioners (ACNP) for 9.5 CPD hours.
• All participants who attend the course in full will be awarded a Statement of Attendance.

Funding:

This activity is funded by the Western Australian Department of Health.

Target Audience:

General Practitioners, Nurse Practitioners, other community based medical practitioners based in WA.